G.CLIPS biotech created the first enabling technology to unravel the potential of drug and antibody candidates on pathology-like format membrane proteins to be used in screening efforts, characterization, structural studies, mechanism of action, pharmacological profiling and target validation.
We offer a unique technology to express, stabilize, select and validate membrane proteins as targets based on proprietary G.Screen® Platform.

 G.Mixes®
 G.Select® Assay
 G.Lipidomics®
 G.Validation® Assay

We provide tailor-made services to pharma, biotech and animal health companies targeting membrane proteins (GPCRS, Receptors, Transmebrane Proteins) that would like to ascertain the necessary environment and conformation stabilization for their targets at all steps of development.
G.CLIPS biotech works on solutions in early discovery steps allowing targets to be in a pathology-like format for screening efforts, immunizations and in vitro testing.

G.CLIPS biotech

Org chart

Teams

Offices

G.CLIPS biotech

Org chart

Teams

Offices

Related companies